Preoperative Portal Vein Embolization for Extended Hepatectomy

Annals of Surgery

Volumn 237, Issue 5, 2003, Pages 686-693

  Hemming, Alan W ^a,c   Reed, Alan I ^a   Howard, Richard J ^a   Fujita, Shiro ^a   Hochwald, Steven N ^a   Caridi, James G ^a   Hawkins, Irvin F ^a   Vauthey, Jean Nicolas ^b   Blumgart, Leslie H ^d   Chapman, William ^d   Farmer, Douglas ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DIURETIC AGENT; FRESH FROZEN PLASMA;

ADULT; AGED; ARTIFICIAL EMBOLISM; ASCITES; BILE DUCT CARCINOMA; BLEEDING; BLOOD CLOTTING DISORDER; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DEMOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATIC VEIN; HUMAN; INFERIOR CAVA VEIN; INOPERABLE CANCER; KLATSKIN TUMOR; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PORTAL VEIN; PORTAL VEIN EMBOLIZATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SURGICAL MORTALITY; TUMOR VOLUME; ARTICLE; BILE DUCT TUMOR; COHORT ANALYSIS; COLORECTAL TUMOR; LIVER; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREOPERATIVE CARE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTAL VEIN; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0842331616     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200305000-00011     Document Type: Conference Paper

References (31)

1. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
2. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-407.
3. Choti MA, Bowman HM, Pitt HA, et al. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg. 1998;2:11-20.
4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-321.
5. Hemming AW, Sielaff TD, Gallinger S, et al. Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl. 2000;6:97-101.
6. Couinaud C. Le Foie: Etudes Anatomicales et Chirurgicales. Paris: Masson & Cie; 1957:187-208.
7. Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg. 2001;192:47-53.
8. Hemming AW, Langham MR, Reed AI, et al. Resection of the inferior vena cava for hepatic malignancy. Am Surg. 2001;67):1081-1088.
9. Hemming AW, Reed AI, Langham MR, et al. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg. 2002;235:850-858.
10. Shirabe K, Shimada M, Gion T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304-309.
11. Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10:803-808.
12. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521-527.
13. Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002;137:675-681.
14. Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8:233-240.
15. Madoff DC, Hicks ME, Vauthey JN, et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics. 2002;22:1063-1076.
16. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512-519.
17. Strasberg SM, for the International Hepato-Pancreato-Biliary Association Terminology Committee Survey. The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB. 2000;2:333-339.
18. Hemming AW, Cattral MS. Ex vivo liver resection with replacement of the inferior vena cava and hepatic vein replacement by transposition of the portal vein. J Am Coll Surg. 1999;189:523-526.
19. Sugawara Y, Makuuchi M, Takayama T, et al. Small-for-size grafts in living-related liver transplantation. J Am Coll Surg. 2001;192:510-513.
20. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232:665-672.
21. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165-175.
22. Kubo S, Shiomi S, Tanaka H, et al. Evaluation of the effect of portal vein embolization on liver function by (99m)Tc-galactosyl human serum albumin scintigraphy. J Surg Res. 2002;107:113.
23. Kudo M, Todo A, Ikekubo K, et al. Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin. Hepatology. 1993;17:814-819.
24. Vera DR, Topcu SJ, Stadalnik RC. In vitro quantification of asialoglycoprotein receptor density from human hepatic microsamples. Methods Enzymol. 1994;247:394-402.
25. Yumoto Y, Umeda M, Ohshima K, et al. Estimation of remnant liver function before hepatectomy by means of technetium-99m-diethylene-triamine-pentaacetic acid galactosyl human albumin. Cancer Chemother Pharmacol. 1994;33:S1-6.
26. Elias D, De Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784-788.
27. Panis Y, Ribeiro J, Chretien Y, et al. Dormant liver metastases: an experimental study. Br J Surg. 1992;79:221-223.
28. Picardo A, Karpoff HM, Ng B, et al. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery. 1998;124:57-64.
29. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480-486.
30. Wakabayashi H, Ishimura K, Okano K, et al. Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer. 2001;92:2384-2390.
31. Kokudo N, Tada K, Seki M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001;34:267-272.